Gout and Cosmetic Surgery: Why Operations Trigger Flares Days Later, Why Allopurinol Should Usually Not Be Stopped, How Colchicine and Steroids Fit a Recovery Plan, and Why a Hot Swollen Ankle After Surgery Needs a Diagnosis, Not a Guess

The patient is 52, had a lower body lift after losing 70 pounds, and went home on the evening of surgery feeling better than expected. On the fourth morning they woke up with a big toe that was red, shiny, hot, and so painful that the bedsheet resting on it felt unbearable. The surgical office, reached by phone, worried about a blood clot and sent them to the emergency room. The emergency physician worried about infection. Nobody had asked, at the consultation, whether the patient had ever had gout. They had, twice, years earlier, and they had stopped their allopurinol the week before surgery because the pre-op instructions said to "hold all non-essential medications."

That sequence is common, avoidable, and rarely discussed in cosmetic surgery. Gout is not a reason to skip an operation. It is a reason to plan one carefully, because the stress of surgery is among the most consistent triggers of a flare, and the timing of that flare lands squarely in the part of recovery when patients are least supervised. What follows is why surgery sets gout off, what to do with the medications, how to treat a flare without compromising the incisions, and how to tell gout from the complications it imitates.

Why surgery is one of gout's favorite triggers

The short answer: gout flares when uric acid levels shift rather than simply when they are high, and an operation shifts them through fasting, fluid changes, blood loss, stress, and interrupted medications all at once.

Gout is an inflammatory arthritis caused by crystals of monosodium urate forming in and around joints. Those crystals form when uric acid in the blood stays above its saturation point, around 6.8 milligrams per deciliter, for long enough. National survey data published by researchers using the National Health and Nutrition Examination Survey estimate that roughly 4 percent of American adults, more than 9 million people, have gout. It is more common in men, and in women it rises sharply after menopause, when estrogen's effect of helping the kidneys excrete uric acid fades.

The counterintuitive part is that flares are often triggered by a change in uric acid levels in either direction. A rise encourages new crystals to form. A sudden fall can loosen crystals already embedded in the joint lining, and the immune system reacts to the newly exposed crystals with an intense inflammatory response. This is why people starting uric acid lowering medication commonly flare in the first months of treatment, and why a period of disruption, like an operation, can set off a joint that has been quiet for years.

Surgery stacks several of these disruptions together. The pre-op fast and post-op nausea cause dehydration, which concentrates uric acid. Blood loss and fluid shifts change how the kidneys handle it. The stress response and tissue injury release inflammatory signals that lower the threshold for a flare. Large operations break down tissue and release purines, the building blocks that the body converts into uric acid. Some routine medications raise uric acid, including thiazide and loop diuretics and low-dose aspirin. And patients often skip their gout medications around the operation, sometimes on instruction, sometimes simply because the routine is broken.

Studies of postoperative gout, mostly from orthopedic and general surgery populations, consistently find that flares cluster in the first week, most often between the second and fifth day. In patients with a known gout history, the published flare rates after surgery have ranged widely, from under 10 percent to more than 20 percent depending on the operation and the population. That is high enough to plan for in every patient who has ever had a flare.

Body contouring patients deserve special attention for a second reason. Gout travels with the metabolic conditions that bring people to these consultations: obesity, insulin resistance, high blood pressure, chronic kidney disease, and fatty liver disease. Rapid weight loss itself can raise uric acid temporarily, which is why studies after bariatric surgery show a spike in flares in the first weeks, followed by a long-term fall as weight stabilizes. The patient planning a lower body lift or a panniculectomy after massive weight loss is often exactly the patient at highest risk.

Allopurinol, febuxostat, and the instruction to stop everything

The short answer: uric acid lowering medication should usually continue through surgery, including on the morning of the operation, because stopping it is itself a common cause of the flare it was meant to prevent.

The American College of Rheumatology's 2020 gout guideline sets out the modern approach plainly. Patients with frequent flares, tophi, or visible joint damage should be on a uric acid lowering drug, with the dose adjusted until the blood level stays below 6 milligrams per deciliter, a strategy called treat to target. Allopurinol is the first-choice drug for most people. Febuxostat is an alternative, though in 2019 the FDA added a boxed warning about a higher rate of cardiovascular death seen with it compared with allopurinol in a large safety trial, and it is now generally reserved for patients who cannot take allopurinol. Probenecid, which helps the kidneys excrete uric acid, is used less often.

The guideline also recommends continuing uric acid lowering therapy during a flare rather than stopping it. The same logic applies to surgery. Pre-op instruction sheets that tell patients to hold "all non-essential medications" or "all pills except blood pressure medicine" sweep allopurinol into the pile. A week without it lets uric acid rise; restarting it afterward drops it again; and the joint is exposed to two swings in a fortnight. Unless the surgeon or anesthesiologist has a specific reason, such as a new kidney problem, allopurinol is generally taken as usual, including with a sip of water on the morning of surgery, under the same rules that govern other day-of-surgery medications.

Timing matters in the other direction too. A patient who has just started allopurinol is in the highest-risk window for flares, because the falling uric acid is loosening old crystals. The ACR recommends anti-inflammatory prophylaxis, usually low-dose colchicine, for three to six months after starting treatment. Starting allopurinol two weeks before an elective operation is a reliable way to schedule a flare into recovery. If a patient's gout is newly diagnosed or poorly controlled, the sensible sequence is to start treatment, let the prophylaxis period run, and book the operation once the uric acid has been at target for a few months.

A few interactions belong on the surgical team's radar. Allopurinol taken with ampicillin or amoxicillin raises the rate of skin rash, which can be mistaken for a reaction to dressings or tape. Probenecid slows the kidneys' clearance of penicillins and cephalosporins, including cefazolin and cephalexin, the antibiotics most commonly given around cosmetic surgery, which raises their blood levels; the piece on antibiotics after cosmetic surgery covers when those are used at all. For patients of Han Chinese, Korean, or Thai ancestry, and for some African American patients, the ACR advises testing for the HLA-B*5801 gene variant before starting allopurinol, because it marks a much higher risk of a severe and sometimes fatal skin reaction. That test belongs before treatment begins, not in the week of surgery.

Patients with severe, treatment-resistant gout sometimes receive pegloticase (Krystexxa), an intravenous infusion every two weeks, often combined with methotrexate to keep it working. Those patients need the infusion schedule and the methotrexate coordinated with the operation by their rheumatologist, because methotrexate affects wound healing and infection risk, and a missed infusion can reduce the drug's effectiveness when restarted.

Colchicine, NSAIDs, and steroids: preventing and treating a flare without harming the incisions

The short answer: low-dose colchicine is the usual tool for prevention around surgery, while treatment of an established flare uses colchicine, an NSAID, or a steroid, chosen around the bleeding, kidney, and wound-healing concerns of the particular operation.

For patients with frequent flares, many rheumatologists recommend low-dose colchicine starting a few days before surgery and continuing for one to two weeks afterward, typically 0.6 milligrams once or twice a day. The evidence for this is mostly observational, from studies showing fewer postoperative flares in patients who received it, but colchicine at that dose is inexpensive, familiar, and well tolerated by most people. Its main side effects are diarrhea and nausea, which matter after surgery: a patient already battling postoperative nausea or opioid-related bowel problems may need the dose adjusted.

Colchicine also has some genuinely dangerous drug interactions. Strong inhibitors of the CYP3A4 enzyme and the P-glycoprotein transporter, including clarithromycin, ketoconazole, itraconazole, ritonavir, and cyclosporine, can push colchicine to toxic levels, and the FDA label carries specific warnings and dose reductions for these combinations. Moderate inhibitors such as diltiazem, verapamil, fluconazole, and grapefruit juice also raise levels. Dosing must be reduced in significant kidney or liver disease. Nobody should take colchicine around surgery without the whole team seeing the full medication list.

When a flare happens anyway, the ACR lists colchicine, NSAIDs, and glucocorticoids as equally acceptable first-line options, and the choice in a surgical patient comes down to the operation. NSAIDs such as naproxen and indomethacin work well for gout, and they are often already part of an opioid-sparing recovery plan. But some surgeons avoid them in the first days after facelifts and other operations where a hematoma would be costly, and they are a poor choice in chronic kidney disease, a common companion of gout. The piece on ibuprofen and NSAIDs after cosmetic surgery covers the bleeding question in detail.

Steroids are often the most practical choice after surgery: a short course of oral prednisone, an injection into the affected joint, or a single intramuscular dose. They work quickly and avoid the bleeding and kidney concerns of NSAIDs. The tradeoffs are a temporary rise in blood sugar, which matters for patients with diabetes (see the piece on blood sugar and cosmetic surgery), and a small effect on wound healing that is usually acceptable for a short course. The earlier piece on steroids for swelling after plastic surgery explains why short courses are generally considered compatible with healing. A single dose of dexamethasone given for nausea during anesthesia should not be counted on to prevent a flare days later.

Pain control deserves a word. Opioids do little for the inflammation of gout and add constipation, a significant concern after body contouring. Treating the inflammation is what relieves the pain. Ice on the affected joint helps, and elevation does too, which happens to be compatible with most recovery positions. A flare usually begins to settle within a few days of treatment, and treating it within the first 24 hours shortens it considerably.

"

The most common cause of a gout flare after cosmetic surgery is not the operation itself. It is the allopurinol the patient was told to stop, or the one they started two weeks before, and both are decisions made at the consultation desk.

"

The hot swollen joint after surgery: gout, clot, infection, or pseudogout

The short answer: a red, hot, swollen joint after surgery can be gout, but it can also be a blood clot, cellulitis, a joint infection, or calcium crystal arthritis, and the treatments are different enough that the diagnosis should be confirmed rather than assumed.

The patient at the top of this piece was sent to the emergency room for a reason. A swollen, painful lower leg in the first week after a large body contouring operation is a blood clot until proven otherwise, and a red, hot area of skin near an incision raises the question of infection. Gout can mimic both. A flare in the ankle or the top of the foot produces redness and swelling that can spread well beyond the joint, looking like cellulitis. A flare in the knee or ankle produces calf and ankle swelling that resembles a clot. Gout can also produce a fever, which overlaps with the fever after plastic surgery that sends many patients back to the office.

The clues that favor gout are a known history of flares, a single joint involved (most often the big toe, the top of the foot, the ankle, or the knee), very rapid onset over hours, and pain severe enough that light touch is intolerable. But clues are not a diagnosis. The definitive test is drawing fluid from the joint with a needle and looking for urate crystals under a polarized light microscope, which also rules out a joint infection. A uric acid blood test is less helpful than people expect: levels often fall during a flare, so a normal result does not exclude gout. When a clot is a real possibility, an ultrasound of the leg veins is needed regardless.

Calcium pyrophosphate deposition disease, often called pseudogout, deserves a mention because it also flares after surgery and is more common in older patients. It most often affects the knee or the wrist, and the crystals look different under the microscope. Treatment overlaps with gout, but the long-term management does not, because allopurinol does nothing for it.

Procedures on the legs complicate the picture further. After knee and ankle liposuction, a thigh lift, or a lower body lift, swelling around the ankles is expected for weeks, as the swelling timeline explains. A patient with a gout history should know what normal postoperative swelling looks like and what a flare looks like, so they can report the difference: ordinary swelling is soft, gradual, and symmetrical, while a flare is hot, red, exquisitely tender, and usually centered on one joint. Hand procedures raise a parallel issue. Gout can affect the finger joints and the wrist, and a patient planning hand rejuvenation with visible gout nodules in the fingers needs that addressed first.

Tophi: the lumps that look cosmetic and are not

The short answer: tophi are deposits of urate crystals under the skin that can look like cysts or nodules on the ears, fingers, elbows, and feet, and they are treated with uric acid lowering medication first, with surgery reserved for complications.

Years of uncontrolled gout can produce tophi, chalky collections of urate crystals surrounded by inflammatory tissue. They appear most often on the rim of the ear, the fingers, the elbows (sometimes within the olecranon bursa, the fluid sac at the tip of the elbow), the Achilles tendon, and the feet. They can be firm or soft, white or yellowish beneath thin skin, and they are sometimes the first sign of gout a patient has noticed. Plastic and dermatologic surgeons see them because patients book appointments thinking they have a cyst or lipoma, or a nodule on the ear they want removed.

The important point is that tophi shrink and can disappear with sustained treatment. Keeping uric acid below the target level, the ACR recommends a stricter goal below 5 milligrams per deciliter in some patients with tophi, dissolves crystals over months to years. Surgical removal is generally reserved for tophi that ulcerate, become infected, compress a nerve or tendon, limit joint movement, or cause disfigurement that persists after medical treatment. Published surgical series report substantial rates of delayed healing and wound breakdown after tophus excision, because the overlying skin is often thin and the urate material can be difficult to clear completely. The earlier piece on wound dehiscence covers why compromised skin heals slowly.

When a nodule is removed and the surgeon finds chalky white material inside, the pathology report can confirm urate crystals, provided the specimen is handled correctly; standard formalin fixation can dissolve urate crystals, so a surgeon who suspects a tophus may send part of the tissue in alcohol or ask the pathologist to look for them. A patient who learns from a pathology report that the "cyst" was a tophus has learned something more important than what the lump was: they have gout that needs treatment, whether or not they have ever had a painful joint.

Tophi also signal how much urate the body is carrying, which feeds back into surgical planning. A patient with visible tophi has a high crystal burden and a higher risk of a postoperative flare, and is usually better served by a period of treatment to target before any elective operation. The same applies to patients with frequent flares: two or more a year is generally considered an indication to start uric acid lowering therapy, and it makes sense to do so well before an elective date rather than in the weeks leading up to it.

Lifestyle advice around gout has a reputation for moralizing, and the evidence supports a more measured version. Beer and spirits raise uric acid more than wine; sugary drinks sweetened with fructose raise it too; very large meat and shellfish meals can trigger flares in susceptible people. The pieces on alcohol before cosmetic surgery and coffee and caffeine before and after surgery apply here, and coffee drinkers may be pleased to know that coffee is associated with lower uric acid levels in observational studies. Steady hydration in recovery matters more than any single food. For patients losing weight on GLP-1 drugs before surgery, gradual weight loss lowers uric acid over time, but the early months of rapid change are worth mentioning to a rheumatologist, and BP medications can be chosen with gout in mind: losartan modestly lowers uric acid, while thiazide diuretics raise it.

The honest summary

Gout is common among people seeking body contouring and other cosmetic surgery, and it is rarely a reason not to operate. It is a reason to plan. Surgery is a reliable trigger of flares, usually within two to five days, through dehydration, fluid shifts, stress, tissue breakdown, and interrupted medications. Most of those flares are preventable.

The planning is not complicated. Every patient should be asked at consultation whether they have ever had gout, and the answer should change the instructions. Allopurinol and other uric acid lowering drugs should usually continue through surgery rather than being swept into a list of medications to hold. Treatment should not be started in the weeks before an elective operation; the better sequence is to reach the uric acid target first and book surgery afterward. Patients with frequent flares or tophi should discuss low-dose colchicine prophylaxis around the operation, checked against every other drug they will take. If a flare does happen, colchicine, an NSAID, or a short steroid course can treat it, chosen around the bleeding, kidney, and wound concerns of the particular procedure.

And a hot, swollen joint after surgery should be diagnosed rather than guessed at, because a blood clot, cellulitis, joint infection, and pseudogout all wear similar clothes. The patient with a combined procedure and a long recovery, or anyone relying on a caregiver in the first days at home, should know in advance who to call and what will be checked. The preoperative testing panel can include a uric acid level and kidney function for any patient with a gout history, at almost no additional cost.

The patient at the top of this piece had a negative leg ultrasound, a joint aspiration that showed urate crystals, and a short course of prednisone that settled the toe within three days. Their incisions healed on schedule. When they returned months later for a second-stage procedure, the plan was different: allopurinol continued through the morning of surgery, colchicine for a week on either side, a uric acid level checked at pre-op, and a written instruction about what a flare looks like and who to call. The second recovery passed without one.